• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Medical treatment – Market size and forecast 2019-2024
o Preventive healthcare – Market size and forecast 2019-2024
o Market opportunity by Application
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Products – Market size and forecast 2019-2024
o Services – Market size and forecast 2019-2024
o Solutions – Market size and forecast 2019-2024
o Market opportunity by Type
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o A&D Co. Ltd.
o Abbott Laboratories
o B. Braun Melsungen AG
o Exergen Corp.
o F. Hoffmann-La Roche Ltd.
o Fresenius Medical Care AG & Co. KGaA
o Johnson & Johnson
o Koninklijke Philips NV
o Linde plc
o Omron Healthcare Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ billion)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: Application – Market share 2019-2024 (%)
• 23: Comparison by Application
• 24: Medical treatment – Market size and forecast 2019-2024 ($ billion)
• 25: Medical treatment – Year-over-year growth 2019-2024 (%)
• 26: Preventive healthcare – Market size and forecast 2019-2024 ($ billion)
• 27: Preventive healthcare – Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Application
• 29: Type – Market share 2019-2024 (%)
• 30: Comparison by Type
• 31: Products – Market size and forecast 2019-2024 ($ billion)
• 32: Products – Year-over-year growth 2019-2024 (%)
• 33: Services – Market size and forecast 2019-2024 ($ billion)
• 34: Services – Year-over-year growth 2019-2024 (%)
• 35: Solutions – Market size and forecast 2019-2024 ($ billion)
• 36: Solutions – Year-over-year growth 2019-2024 (%)
• 37: Market opportunity by Type
• 38: Customer landscape
• 39: Market share by geography 2019-2024 (%)
• 40: Geographic comparison
• 41: North America – Market size and forecast 2019-2024 ($ billion)
• 42: North America – Year-over-year growth 2019-2024 (%)
• 43: Europe – Market size and forecast 2019-2024 ($ billion)
• 44: Europe – Year-over-year growth 2019-2024 (%)
• 45: Asia – Market size and forecast 2019-2024 ($ billion)
• 46: Asia – Year-over-year growth 2019-2024 (%)
• 47: ROW – Market size and forecast 2019-2024 ($ billion)
• 48: ROW – Year-over-year growth 2019-2024 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ billion)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: A&D Co. Ltd. – Overview
• 58: A&D Co. Ltd. – Business segments
• 59: A&D Co. Ltd. – Key offerings
• 60: A&D Co. Ltd. – Key customers
• 61: A&D Co. Ltd. – Segment focus
• 62: Abbott Laboratories – Overview
• 63: Abbott Laboratories – Business segments
• 64: Abbott Laboratories – Key offerings
• 65: Abbott Laboratories – Key customers
• 66: Abbott Laboratories – Segment focus
• 67: B. Braun Melsungen AG – Overview
• 68: B. Braun Melsungen AG – Business segments
• 69: B. Braun Melsungen AG – Key offerings
• 70: B. Braun Melsungen AG – Key customers
• 71: B. Braun Melsungen AG – Segment focus
• 72: Exergen Corp. – Overview
• 73: Exergen Corp. – Product and service
• 74: Exergen Corp. – Key offerings
• 75: Exergen Corp. – Key customers
• 76: Exergen Corp. – Segment focus
• 77: F. Hoffmann-La Roche Ltd. – Overview
• 78: F. Hoffmann-La Roche Ltd. – Business segments
• 79: F. Hoffmann-La Roche Ltd. – Key offerings
• 80: F. Hoffmann-La Roche Ltd. – Key customers
• 81: F. Hoffmann-La Roche Ltd. – Segment focus
• 82: Fresenius Medical Care AG & Co. KGaA – Overview
• 83: Fresenius Medical Care AG & Co. KGaA – Business segments
• 84: Fresenius Medical Care AG & Co. KGaA – Key offerings
• 85: Fresenius Medical Care AG & Co. KGaA – Key customers
• 86: Fresenius Medical Care AG & Co. KGaA – Segment focus
• 87: Johnson & Johnson – Overview
• 88: Johnson & Johnson – Business segments
• 89: Johnson & Johnson – Key offerings
• 90: Johnson & Johnson – Key customers
• 91: Johnson & Johnson – Segment focus
• 92: Koninklijke Philips NV – Overview
• 93: Koninklijke Philips NV – Business segments
• 94: Koninklijke Philips NV – Key offerings
• 95: Koninklijke Philips NV – Key customers
• 96: Koninklijke Philips NV – Segment focus
• 97: Linde plc – Overview
• 98: Linde plc – Business segments
• 99: Linde plc – Key offerings
• 100: Linde plc – Key customers
• 101: Linde plc – Segment focus
• 102: Omron Healthcare Inc. – Overview
• 103: Omron Healthcare Inc. – Product and service
• 104: Omron Healthcare Inc. – Key offerings
• 105: Omron Healthcare Inc. – Key customers
• 106: Omron Healthcare Inc. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations
【掲載企業】
A&D Co. Ltd., Abbott Laboratories, B. Braun Melsungen AG, Exergen Corp., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Koninklijke Philips NV, Linde plc, Omron Healthcare Inc.
【免責事項】
https://www.marketreport.jp/reports-disclaimer